AlloDerm ®

AlloDerm ®

AlloDerm ®

Product catalog summary
Introduction
LifeCell™ has been a pioneer in developing innovative products for over two decades, significantly impacting surgical procedures and patient outcomes. The timeline highlights key milestones in the development and application of AlloDerm® Regenerative Tissue Matrix (RTM) and other products.

Timeline of Developments
  • 1986: LifeCell Corporation formed.
  • 1994: Introduction of burn treatment.
  • 1998: Launch of AlloDerm® RTM for dental applications.
  • 2000-2012: Expansion into hernia repair, breast reconstruction, and other surgical applications.

Tissue Recovery and Processing
  • LifeCell™ collaborates with FDA Registered 3rd Party Tissue Recovery Partners to ensure ethical procurement and comprehensive screening of donor tissues.
  • Donor blood samples are rigorously tested for infectious diseases, and tissues are screened for microbial contaminants.
  • LifeCell™ employs a patented acellular process to remove cells from the dermal tissue without damaging its structure.

Patented Acellular Process
  • The process involves non-damaging freeze-drying that preserves the structural integrity of the dermis, avoiding inflammation and rejection.
  • Conventional freeze-drying can disrupt the dermal architecture, leading to potential immune responses.

Quality and Processing
  • The final AlloDerm® RTM product is free of cells and microbial pathogens, with a demonstrated viral reduction of over 99.9%.
  • The matrix retains its critical biochemical components, ensuring its effectiveness in surgical applications.

Comparative Histology
  • AlloDerm® RTM maintains an intact basement membrane and dermal structure, unlike other products which show modifications and cellular remnants.

Conclusion
LifeCell™ continues to advance surgical techniques and improve patient outcomes through its innovative tissue matrix products, supported by rigorous quality control and processing standards.
See more

Catalog excerpts

AlloDerm ®-1

AlloDerm Regenerative Tissue Matrix (RTM) ® check the history and processing Advancing surgery and improving patients’ lives LifeCell™ timeline For over two decades, LifeCell™ has developed innovative products for use in a wide range of applications. Our success could not have been possible without the insight and guidance of healthcare professionals. burn treatment LifeCell Corporation formed Strattice™ Reconstructive Tissue Matrix (RTM) head and neck reconstruction breast reconstruction challenging hernia repair AlloDerm® RTM for breast reconstruction available in bi-lateral pairs breast plastic surgery with Strattice™ RTM LifeCell™ quality and processing more than 1.4 million grafts to date Tissue recovery Patented acellular process • Independent, FDA Registered 3rd Party Tissue Recovery Partners (TRP) obtain consent for procurement of the tissue • Comprehensive medical and social history screening meets FDA and AATB criteria • Donor blood sample is tested and must be found negative for infectious diseases including HIV and Hepatitis B & C • Tissue samples are screened for microbial contaminants and must be free of pathogenic bacteria • LifeCell™ medical directors determine donor eligibility per AATB standards and FDA regulations Non-damaging steps designed to: Non-damaging freeze-drying: • Remove cells on surface of skin • Remove cells deep in the dermal tissue • Process creates an amorphous ice that retains the structural integrity of the complex microarchitecture of the dermis1 • Non-destructive drying and packaging for storage Final AlloDerm RTM product ® • No cells detected • Although donor tissues are screened for infectious diseases, the LifeCell™ patented acellular dermal matrix processing demonstrates >99.9% viral reduction • No microbial pathogens detected • Intact matrix and critical biochemical components SPMP12289 REV A DEC 2012 During conventional freeze-drying, hexagonal ice crystals form, disrupting the normal architecture of this layer and rendering the damaged matrix susceptible to inflammation and rejection, because the hosts immune system regards the fragmented subunits as individual foreign bodies.1 40x magnification, Verhoeff-van Geison (stain for elastin) LifeCell™ patented freeze-drying did not alter the m

 Open the catalog to page 1
AlloDerm ®-2

AlloDerm Regenerative Tissue Matrix (RTM) ® check the out of package histology 1 Human Dermis Intact basement membrane Papillary dermis Basket weave configuration Reticular dermis Cells Epidermis Papillary dermis Reticular dermis Basement membrane Puros Dermis 1) Modified basement membrane, no undulation 2) Cellular remnants 1) No basement membrane 2) Modified collagen bundle (Non-human extracellular matrix) 1) Separation between collagen bundles 2) Cellular remnants 1) LH Holton, D Kim, RP Silverman, ED Rodriguez, N Singh, NH Goldberg. Human acellular dermal matrix for repair of abdominal wall...

 Open the catalog to page 2

Archived catalogs

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.